Cargando…

17-alpha hydroxyprogesterone caproate for the prevention of recurrent preterm birth among singleton pregnant women with a prior history of preterm birth: a systematic review and meta-analysis of six randomized controlled trials

To perform a systematic review and meta-analysis of all randomized controlled trials (RCTs) that investigated the clinical benefits of 17-alpha hydroxyprogesterone caproate (17OHPC) in the prevention of recurrent preterm birth (PTB) among singleton pregnant women with a previous history of PTB. We s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Baradwan, Saeed, Abdulghani, Sahar Hassan, Abuzaid, Mohammed, Khadawardi, Khalid, Alshahrani, Majed Saeed, Al-Matary, Abdulrahman, AlRasheed, May A., Miski, Najlaa Talat, Abdulhalim, Aroob, Alturki, Yousra Mansour, Abu-Zaid, Ahmed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Obstetrics and Gynecology 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8595047/ https://www.ncbi.nlm.nih.gov/pubmed/34670064 http://dx.doi.org/10.5468/ogs.21264

Ejemplares similares

Safety review of hydroxyprogesterone caproate in women with a history of spontaneous preterm birth
por: Sibai, Baha, et al.
Publicado: (2020)

Critical appraisal of the efficacy, safety, and patient acceptability of hydroxyprogesterone caproate injection to reduce the risk of preterm birth
por: Vidaeff, Alex C, et al.
Publicado: (2013)

Patient and Provider Perspectives on Acceptability, Access, and Adherence to 17-Alpha-Hydroxyprogesterone Caproate for Preterm Birth Prevention
por: Garcia, Stephanie M., et al.
Publicado: (2021)

Evaluation the effect of 17-alpha hydroxyprogesterone caproate on gestational diabetes mellitus in pregnant women at risk for preterm birth
por: Rouholamin, Safoura, et al.
Publicado: (2015)

Development and usability of a new subcutaneous auto-injector device to administer hydroxyprogesterone caproate to reduce the risk of recurrent preterm birth
por: Travanty, Michael N, et al.
Publicado: (2018)

17-Hydroxyprogesterone Caproate for the Prevention of Recurrent Preterm Birth – A Systematic Review and Meta-analysis Taking into Account the PROLONG Trial
por: Kuon, Ruben-J., et al.
Publicado: (2021)

Intramuscular 17-hydroxyprogesterone caproate to prevent preterm birth among HIV-infected women in Zambia: study protocol of the IPOP randomized trial
por: Price, Joan T., et al.
Publicado: (2019)

Weekly 17 alpha-hydroxyprogesterone caproate to prevent preterm birth among women living with HIV: a randomised, double-blind, placebo-controlled trial
por: Price, Joan T, et al.
Publicado: (2021)

Can 17 hydroxyprogesterone caproate (17P) decrease preterm deliveries in patients with a history of PMC or pPROM?
por: Cohen, Gal, et al.
Publicado: (2022)

Comparison of oral Dydrogesterone and 17-α hydroxyprogesterone caprate in the prevention of preterm birth
por: Alizadeh, Fahimeh, et al.
Publicado: (2022)

Association of Preterm Singleton Birth With Fertility Treatment in the US
por: Wang, Ran, et al.
Publicado: (2022)

Quality investigation of hydroxyprogesterone caproate active pharmaceutical ingredient and injection
por: Chollet, John L., et al.
Publicado: (2012)

Pharmacokinetics of Hydroxyprogesterone Caproate and its Primary Metabolites during Pregnancy
por: Boggess, Kim A., et al.
Publicado: (2018)

17-Hydroxyprogesterone caproate to prolong pregnancy after preterm rupture of the membranes: early termination of a double-blind, randomized clinical trial
por: Combs, C Andrew, et al.
Publicado: (2011)

The Influence of Prior Obstetrical History on Current 17-Hydroxyprogesterone Caproate Use
por: Ransom, Carla E., et al.
Publicado: (2011)

Association between Maternal Factors, Preterm Birth, and Low Birth Weight of Chilean Singletons
por: Rodríguez-Fernández, Alejandra, et al.
Publicado: (2022)

Development and validation of a nomogram to predict spontaneous preterm birth in singleton gestation with short cervix and no history of spontaneous preterm birth
por: Sun, Yongkang, et al.
Publicado: (2023)

17-Alpha-Hydroxyprogesterone vs. Placebo for Preventing of Recurrent Preterm Birth: A Systematic Review and Meta-Analysis of Randomized Trials
por: Almutairi, Abdulaali R., et al.
Publicado: (2021)

Effects of greenness on preterm birth: A national longitudinal study of 3.7 million singleton births
por: Zhang, Lina, et al.
Publicado: (2022)

Comparison of perinatal outcomes in late preterm birth between singleton and twin pregnancies
por: Yoo, Eun-Hye, et al.
Publicado: (2017)

The variation of antenatal corticosteroids administration for the singleton preterm birth in China, 2017 to 2018
por: Wang, Qing, et al.
Publicado: (2022)

Estimating the individual singleton preterm birth risk: nomogram establishment and independent validation
por: Gao, Ting, et al.
Publicado: (2023)

Technology-free predictors of preterm birth in singleton women with threatened preterm labor: a prospective cohort study
por: Najjarzadeha, Maryam, et al.
Publicado: (2022)

Joint Modeling of Singleton Preterm Birth and Perinatal Death Using Birth Registry Cohort Data in Northern Tanzania
por: Mboya, Innocent B., et al.
Publicado: (2021)

Functional effects of 17alpha-hydroxyprogesterone caproate (17P) on human myometrial contractility in vitro
por: Sexton, Donal J, et al.
Publicado: (2004)

Comparison of intravaginal progesterone gel and intramuscular 17-α-hydroxyprogesterone caproate in luteal phase support
por: SATIR, FUNDA, et al.
Publicado: (2013)

Primiparous singleton women with endometriosis have an increased risk of preterm birth: Meta-analyses
por: Kim, Sun-Gyeong, et al.
Publicado: (2017)

17-α Hydroxyprogesterone Nanoemulsifying Preconcentrate-Loaded Vaginal Tablet: A Novel Non-Invasive Approach for the Prevention of Preterm Birth
por: Patki, Manali, et al.
Publicado: (2019)

Maternal Characteristics Influencing the Development of Gestational Diabetes in Obese Women Receiving 17-alpha-Hydroxyprogesterone Caproate
por: Egerman, Robert, et al.
Publicado: (2014)

17α-Hydroxyprogesterone Caproate Inhibits Cytokine Production via Suppression of NF-κB Activation
por: Hu, Tao, et al.
Publicado: (2022)

Factors Associated with Singleton Preterm Birth in Shire Suhul General Hospital, Northern Ethiopia, 2018
por: Kelkay, Bayew, et al.
Publicado: (2019)

Preterm Birth in Assisted Reproductive Technology: An Analysis of More Than 20,000 Singleton Newborns
por: Bu, Zhiqin, et al.
Publicado: (2020)

Trends in singleton preterm birth in Victoria, 2007 to 2017: A consecutive cross‐sectional study
por: Burger, Renée J., et al.
Publicado: (2021)

A nomogram to predict extremely preterm birth in women with singleton pregnancies undergoing cervical cerclage
por: Lv, Min, et al.
Publicado: (2022)

Effects of gestational diabetes mellitus and assisted reproductive technology treatment on the risk of preterm singleton birth
por: Gao, Rui, et al.
Publicado: (2022)

Contribution of Risk Factors to Extremely, Very and Moderately Preterm Births – Register-Based Analysis of 1,390,742 Singleton Births
por: Räisänen, Sari, et al.
Publicado: (2013)

Risk Factors of Preterm Birth and Low Birth Weight in Singletons Conceived Through Frozen Embryo Transfer: A Retrospective Study
por: Tang, Haiyu, et al.
Publicado: (2022)

The Association Between Hypertension in Pregnancy and Preterm Birth with Fetal Growth Restriction in Singleton and Twin Pregnancy: Use of Twin Versus Singleton Charts
por: Kalafat, Erkan, et al.
Publicado: (2020)

Reducing the impact of preterm birth: Preterm birth commissioning in the United Kingdom
por: Story, Lisa, et al.
Publicado: (2019)

Clinical Comparison of Preterm Birth and Spontaneous Preterm Birth in Severe Preeclampsia
por: Wen, Yanqing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rb380c42m5a0j0ca8i67e853l5